PAVmed (PAVM) Equity Income (2024 - 2025)
PAVmed's quarterly Equity Income came in at $2.5 million in Q4 2025, up 1903.2% year-on-year from $125000.0 in Q4 2024, and up 157.14% quarter-over-quarter from -$4.4 million in Q3 2025.
PAVmed has reported Equity Income for 2 years, with the latest figure at $2.5 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Income rose 1903.2% year-over-year to $2.5 million; the trailing twelve-month figure through Dec 2025 stood at $8.5 million (changed N/A YoY), and the FY2025 full-year result was $8.5 million, up 1494.55% from the prior year.
- Equity Income for Q4 2025 stood at $2.5 million, up from -$4.4 million in the prior quarter.
- The five-year high for Equity Income was $21.0 million in Q1 2025, with the low at -$10.6 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | 2.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.50 Mn |
| Sep 30, 2025 | -4.38 Mn |
| Jun 30, 2025 | -10.64 Mn |
| Mar 31, 2025 | 21.00 Mn |
| Dec 31, 2024 | 125,000.00 |